Workflow
医保局“反内卷”
icon
Search documents
医保局“反内卷”百项定价引爆科创医药!科创100ETF华夏(588800)盘中震荡
Mei Ri Jing Ji Xin Wen· 2025-08-01 03:29
Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board 100 Index decreased by 0.24% as of August 1, 2025, with mixed performance among constituent stocks [1] - Out of the constituent stocks, Aotewi led the gains with an increase of 7.18%, while Yuanjie Technology experienced the largest decline at 6.20% [1] - The Huaxia Sci-Tech 100 ETF (588800) saw a slight decrease of 0.28%, with a latest price of 1.06 yuan, but had a cumulative increase of 1.53% over the past week [1] Group 2 - The National Healthcare Security Administration (NHSA) has introduced a new pricing mechanism for newly listed drugs to support innovation in pharmaceuticals and medical devices, adding over 100 pricing items related to new medical technologies [1] - The NHSA aims to streamline the pricing and reimbursement process for new technologies and products, facilitating quicker returns on investment for clinically urgent innovations [1] - According to Zhongyin Securities, the national drug procurement has conducted 10 batches covering 435 types of drugs, with previous procurement methods focusing on "price for volume," which negatively impacted profitability and quality for some companies [2]